Home | ClinicalTrials.gov
ClinicalTrials.gov is a website and online database of clinical research studies and information about their results
A 15-WEEK, PHASE 2, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED, DOSE RANGING STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PF …
ClinicalTrials.gov PRS: Login
The Modernized PRS is now the primary website for Protocol Registration and submission of Study Documents and Results. After logging in, you will be directed to the new website. The …
ClinicalTrials.gov PRS: Home page (Beta)
The National Library of Medicine (NLM) has launched an effort to modernize ClinicalTrials.gov. We will be continually delivering improvements throughout the modernization effort.
A Phase I, Open-Label, Single and Multiple Dose (Twice-Daily), Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by …
This document outlines the statistical methods to be implemented during the analyses of data collected within the scope of Zealand Pharma A/S protocol ZP4207-17086. The purpose of …
The Phase 3 Study I3Y-MC-JPBK (JPBK) study will evaluate the clinical activity of abemaciclib plus best supportive care (BSC) versus erlotinib plus BSC for patients with Stage IV NSCLC …
GOT GPT HBV HCV HIV i.v. IB IC ICH IEC IFN IgE IgG IL IMP IRB IRT ISF ITE JDA KO LDH LPLT MedDRA Food and Drug Administration First in human Guillain-Barré syndrome Good …